Who founded Qureator?

Qureator was founded by Kyusuk Baek.

How much funding has Qureator raised?

Qureator has disclosed $6.7M raised across 1 round.

Where is Qureator headquartered?

Qureator is headquartered in San Diego, US.

Qureator

San Diego, US · Delaware corporation

Find your way into Qureator

Your email: who you already know at Qureator, and who your contacts know
2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Qureator team
Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Qureator develops non-animal testing methods for drug development, notably achieving an FDA IND approval without animal proof-of-concept data in collaboration with SillaJen. The company works in preclinical biotech, providing alternatives to animal testing for pharmaceutical partners.

Biotech Deep Tech

Founders & leadership

Kyusuk BaekFounder

Paul ParkConsulting Chief Business Officer

Noo Li JeonNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$6.7M disclosed across 1 round · 2025

▶$6.7MraisedMar 2026 · 1 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Kyusuk BaekExecutive Officer, Director
Noo Li JeonDirector

Offering amount: $6.9M
Amount sold: $6.7M
First sale: Dec 2025
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 3

Cour PharmaCOUR develops antigen-specific immunotherapies that reprogram the immune system to treat the underlying causes of autoimmune and immune-mediated diseases while preserving normal immune function. The company is advancing a pipeline of disease-modifying therapies aimed at patients with a range of autoimmune conditions.

Applied TherapeuticsApplied Therapeutics is a biopharmaceutical company developing novel drugs for rare diseases with high unmet medical need. Its Aldose Reductase Inhibitor franchise is in development across disease areas including Galactosemia and SORD Deficiency.

QuralisQurAlis develops precision therapies for amyotrophic lateral sclerosis (ALS) and related neurodegenerative diseases by targeting specific disease-causing genetic drivers and molecular mechanisms. The company was founded by neuroscientists from Harvard to translate emerging discoveries about disease pathways into treatment breakthroughs for ALS patients.

Companies working in the same space as Qureator.

Frequently asked questions

What does Qureator do?: Qureator develops non-animal testing methods for drug development, notably achieving an FDA IND approval without animal proof-of-concept data in collaboration with SillaJen. The company works in preclinical biotech, providing alternatives to animal testing for pharmaceutical partners.
Who founded Qureator?: Qureator was founded by Kyusuk Baek.
How much funding has Qureator raised?: Qureator has disclosed $6.7M raised across 1 round.
Where is Qureator headquartered?: Qureator is headquartered in San Diego, US.